Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc ICOTF


Primary Symbol: T.MSCL Alternate Symbol(s):  MSCLF

Satellos Bioscience Inc. is a Canada-based a drug discovery and development company with a focus on muscle regeneration. The Company is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.


TSX:MSCL - Post by User

Post by MikeTheFolder!on Jul 13, 2018 10:34am
210 Views
Post# 28311852

Mike here !

Mike here !

As I have said yestarday in my post, I have acquired 50,000 shares at 0.235 per share, and I had an estimate of the price reaching $2.00 - $2.50, or at least this is my price target , because I have done my DD on this stock very very very good, and let me just give you a little insight about me. I purchased VPT when it was 0.06 for 45,000 shares, and sold it at 0.87, because I had a target of 0.80 - 0.90 for VPT, due to my DD that I did on it. What I am trying to say is that my skills at catching stocks like this is very good and has always been good, so I dont ask to be put on ignore, I just ask that you share your thoughts about my insights, because if I buy a stock that went from 0.05 to 0.235, andI purcahse at 0.235 I truly believe that we can reach the price that I have as target, please let me know if you agree with me !! Much appreciate it !  And by the way, today is Friday, and by looking at the trading, we are doing amazing !!  Exactly as I have predicted as well, we are days before news based on my DD, and believe me, my DD prediction is very very good for this news, which can easily take us to a support level of 0.50 !! 

 

$2.00 - $2.50 price target,  thoughts please !!!

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse